Parmax Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/06/2026 ,inter alia, to consider and approve Fund raising
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Parmax Pharma Ltd has informed BSE that its Board of Directors will meet on June 08, 2026, to consider and evaluate a proposal for raising funds. The funds may be raised through issue of equity shares or equity-linked instruments via preferential allotment on a private placement basis, or through any other suitable method. The Board will also approve the draft notice and convene an Extraordinary General Meeting (EGM) to seek shareholder approval for the proposal. The trading window for designated persons has been closed from June 03, 2026 until 48 hours after the board meeting concludes.
This is a forward-looking intimation, so no immediate price impact. If approved, the fund raise could lead to equity dilution for existing shareholders, though it may also strengthen the company's balance sheet for growth or operational needs. Investors should watch for the board meeting outcome and EGM details for specifics on size, pricing, and use of proceeds.